Coastland Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-250,000
Closed -$52.5M 117
2016
Q4
$52.5M Buy
+250,000
New +$51.8M 1.45% 23
2015
Q1
Sell
-200,000
Closed -$51.5M 179
2014
Q4
$51.5M Buy
200,000
+176,500
+751% +$44.1M 2.04% 11
2014
Q3
$5.67M Sell
23,500
-26,000
-53% -$5.82M 0.2% 81
2014
Q2
$11M Hold
49,500
0.57% 51
2014
Q1
$10.2M Buy
+49,500
New +$9.8M 0.41% 59

Other funds holding AGN

Coastland Capital's AGN Position: Q1 2017 in Review

Coastland Capital sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 166,250 shares — an estimated $34.9M sold.

Coastland Capital first reported a position in AGN in Q1 2014 and held it in 4 quarters. The position peaked at $40.7M in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Coastland Capital reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Coastland Capital sold 166,250 Allergan plc shares in Q1 2017, an estimated $34.9M.
  • Coastland Capital first reported a position in Allergan plc in Q1 2014 and held it in 4 quarters.
  • Coastland Capital's Allergan plc position peaked at $40.7M in Q1 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Coastland Capital's 13F filing for Q1 2017, filed 15 May 2017.